Brian Stone
Oral and Maxillofacial Surgery · Tyler, TXNPI 1265650071
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,850 of the $12,377 with a category attached, or 71.5%. Straumann USA LLC accounts for 90.4% of it on its own, with 6 other manufacturers making up the rest. Among oral and maxillofacial surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $442.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$11K
- Kls-martin L.p.$764
- Johnson & Johnson$264
- Zimvie Inc.$59
- Brainlab, Inc.$48
- 3M Company$27
- plus $23 from 1 others
What the payments were for
- Speaking & faculty fees$8,85072%
- Food & beverage$1,95216%
- Gifts$1,57513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 14 | $11,192 |
| Kls-martin L.p. | 5 | $764 |
| Johnson & Johnson | 4 | $264 |
| Zimvie Inc. | 1 | $59 |
| Brainlab, Inc. | 2 | $48 |
| 3M Company | 1 | $27 |
| Salvin Dental Specialties, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,377 in reported general payments places this provider in the 90th percentile of 591 oral and maxillofacial surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 253 | $1,045 |
| Amoxicillin | 186 | $599 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 204 | $399 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $219 |
| Clindamycin Hcl | 15 | $66 |
| Cephalexin | 15 | $58 |
| Cyclobenzaprine Hcl | 13 | $50 |
| Tramadol Hcl | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Tyler
- Wade BarkerTyler$7K
- James MelvilleHouston$239K
- Pedro FrancoIrving$91K
- Fayette WilliamsFort Worth$74K
- Craig BuchmannKeller$69K
- John ZunigaDallas$61K
- David AlfiHouston$58K
- Herman KaoFort Worth$41K
- John ShroyerArlington$41K
- Craig PearlHouston$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.